Smarter Research, Responsible AI

Leveraging Web of Science™ Research Assistant and EndNote 2025
Join this free webinar on June 26 | at 11:00 a.m. IST
As artificial intelligence becomes an integral part of the academic research lifecycle, it is essential for researchers and institutions to approach its use with responsibility and ethical awareness.

This webinar will examine how AI—particularly Web of Science™ Research Assistant and EndNote 2025—can support literature review, improve academic writing, and enhance research efficiency, while upholding academic integrity.

Join us to learn:
  • How to effectively integrate AI tools like Web of Science Research Assistant into research workflows
  • Ethical considerations and potential risks associated with AI use
  • Best practices and institutional guidelines for responsible AI adoption
  • Clarivate’s vision for the future with agentic AI in research and learning

Agenda:

  • The rise of AI in academia & AI Initiatives at Clarivate
  • Ethical Considerations in AI Use – The Clarivate Viewpoint
  • Why Web of Science™ Research Assistant is designed for ethical use
  • How does EndNote 2025 incorporate AI in reference management
  • AI’s Role in Enhancing Research Efficiency-the Web of Science™ Research Assistant Story
  • Best Practices for Responsible AI Use 
  • Limitations and Risks 
  • The Road Ahead: Agentic AI for Research and Learning 
  • How is Clarivate setting new standards for trustworthy AI in academia
  • Interactive Q&A

Register below and we'll send the details.

HIDDEN FIELDS BELOW

Speaker

Dr. Subhasree Nag
Strategic Customer Success Consultant
Clarivate

Dr.  Subhasree  Nag  is  a Strategic Customer Success Consultant  for  the Academic & Government division at Clarivate.  

She  completed  her  PhD  from  Texas  Tech  University  Health  Sciences Center,  USA  and  her  post-doctoral  training  from  Pacific  Northwest National Laboratory, USA.

A pharmacologist and toxicologist by training, she has more than 8 years of  research  experience  in  anticancer  drug  discovery  and pharmacokinetics  areas  with  25  peer  reviewed  publications  and  more than 1500 citations.

At Clarivate, she is involved in promoting Clarivate's scholarly research, drug discovery and intellectual property (IP) solutions, conducting author and research capacity workshops, bespoke consulting projects, etc.

She  was  a  co-author  on  the  UGC-Good  Academic  Research  Practices guidance  document released  in  2020.  She  also  writes for  the  Clarivate pharma  industry  magazine,  Bioworld,  where  she  contributes  to  articles related to early-stage discovery and preclinical studies.